Allena Pharmaceuticals Total Liabilities 2011-2026 | ALNA

Annual Total Liabilities Allena Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
15.9 M	16.4 M	16.9 M	15.8 M	13.4 M	109 M	105 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
109 M	13.4 M	41.7 M

Quarterly Total Liabilities Allena Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	14.1 M	10.1 M	15.9 M	17.8 M	18 M	17 M	16.4 M	16.4 M	16.4 M	16.4 M	16.9 M	16.9 M	16.9 M	16.9 M	15.8 M	15.8 M	15.8 M	15.8 M	13.4 M	13.4 M	13.4 M	13.4 M	13 M	13 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
18 M	10.1 M	15.4 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	6.06 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	6.56 M	-	1.35 %	$ 17.8 M	China
Amphastar Pharmaceuticals AMPH	840 M	$ 16.87	-2.49 %	$ 789 M	USA
AgeX Therapeutics AGE	6.99 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	707 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	215 M	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	65.4 B	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Arcturus Therapeutics Holdings ARCT	57.2 M	$ 7.47	-4.6 %	$ 205 M	Israel
Athira Pharma ATHA	64.4 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	71.5 M	-	0.74 %	$ 768 M	Israel
Galera Therapeutics GRTX	645 K	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	6.77 M	-	-18.52 %	$ 27.3 M	Britain
AbCellera Biologics ABCL	390 M	$ 4.09	-7.05 %	$ 1.22 B	Canada
Coherus BioSciences CHRS	197 M	$ 1.57	-3.68 %	$ 184 M	USA
Autolus Therapeutics plc AUTL	411 M	$ 1.63	2.52 %	$ 434 M	Britain
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
BioNTech SE BNTX	2.76 B	$ 89.55	-2.65 %	$ 21.6 B	Germany
Checkmate Pharmaceuticals CMPI	9.38 M	-	-	$ 231 M	USA
Advaxis ADXS	7.89 M	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	3.45 M	$ 3.36	-3.72 %	$ 5.53 M	Israel
Aeterna Zentaris AEZS	17.6 M	-	5.93 %	$ 314 M	Canada
Eton Pharmaceuticals ETON	66 M	$ 30.26	1.0 %	$ 814 M	USA
Exelixis EXEL	683 M	$ 50.13	-1.9 %	$ 13.6 B	USA
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	470 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	43.5 M	-	1.93 %	$ 17.4 M	USA
Enlivex Therapeutics Ltd. ENLV	392 M	$ 0.72	-1.58 %	$ 32.9 M	Israel
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
Esperion Therapeutics ESPR	768 M	$ 3.12	-	$ 649 M	USA
Aptose Biosciences APTO	37.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	28.4 M	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	126 M	-	-0.23 %	$ 916 M	USA
Fortress Biotech FBIO	123 M	$ 2.41	4.78 %	$ 67.2 M	USA
AlloVir ALVR	42.9 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	74.8 M	-	-	$ 28.6 M	USA
Forte Biosciences FBRX	21.8 M	$ 23.11	-3.55 %	$ 299 M	USA
Arcutis Biotherapeutics ARQT	243 M	$ 21.32	-1.16 %	$ 2.71 B	USA
Fennec Pharmaceuticals FENC	35.1 M	$ 9.75	5.52 %	$ 279 M	USA
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	46.6 M	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	107 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	7.24 M	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	72 M	-	-	$ 8.42 M	USA